S.A. Mason LLC Novo Nordisk A S Transaction History

S.A. Mason LLC

$186 Million
Q4 2024

A detailed history of S.A. Mason LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, S.A. Mason LLC holds 9,678 shares of NVO stock, worth $796,789. This represents 0.45% of its overall portfolio holdings.

Number of Shares

9,678

Previous 9,628 0.52%

Holding current value

$796,789

Previous $1.15 Million 27.4%

% of portfolio

0.45%

Previous 0.62%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$85.0 - $120.04 $4,250 - $6,002	50 Added 0.52%	9,678 $832,000
Q1 2024 Apr 15, 2024	BUY	$102.11 - $135.92 $247,923 - $330,013	2,428 Added 33.72%	9,628 $1.24 Million
Q4 2023 Jan 17, 2024	SELL	$87.78 - $105.45 $26,334 - $31,635	-300 Reduced 4.0%	7,200 $744,000
Q3 2023 Oct 13, 2023	BUY	$90.94 - $199.54 $341,025 - $748,275	3,750 Added 100.0%	7,500 $682,000
Q2 2022 Jul 07, 2022	SELL	$103.24 - $121.81 $15,486 - $18,271	-150 Reduced 3.85%	3,750 $418,000
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $363,090 - $438,906	3,900 New	3,900 $433,000

Others Institutions Holding NVO

# of Institutions

1,876

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $186B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.

Account